[Recurrent autoreactive pericardial effusion. Impact of an aetiological classification of pericarditis]

B Maisch1, K Karatolios, S Pankuweit

  • 1Klinik für Innere Medizin-Schwerpunkt Kardiologie der Universitätsklinikums GmbH Gissen und Marburg, Standort Marburg. Maisch@med.uni-marburg.de

Abstract

Insights

This study highlights an effective treatment for autoreactive pericarditis. Combining intrapericardial triamcinolone with long-term colchicine successfully resolved symptoms and prevented recurrence in a patient with refractory pericardial effusion.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Pathology

Background:

  • A 36-year-old male presented with persistent symptoms including fever, fatigue, and chest pain, initially misdiagnosed as tracheobronchitis.
  • Initial investigations suggested acute myocardial infarction, but coronary angiography ruled out significant coronary artery disease or aortic dissection.

Observation:

  • Echocardiography revealed a small pericardial effusion, characteristic of acute pericarditis, which improved with aspirin and diclofenac.
  • Recurrent symptoms led to the discovery of a large pericardial effusion with signs of cardiac tamponade, including pulsus paradoxus and electrical alternans.

Findings:

  • Pericardiocentesis drained 485 ml of serous fluid, and biopsies showed lymphocytic fibrinous pericarditis.
  • Viral and bacterial polymerase chain reaction (PCR) tests were negative, indicating an autoreactive or idiopathic cause.
  • Intrapericardial triamcinolone and long-term oral colchicine treatment resulted in complete symptom resolution and absence of effusion at 9 months.

Implications:

  • This case demonstrates the efficacy of a combined intrapericardial corticosteroid and oral colchicine regimen for refractory autoreactive pericarditis.
  • The treatment strategy appears to prevent relapses, offering a valuable therapeutic option for similar complex pericardial conditions.
  • Early and accurate diagnosis of pericardial effusion and tamponade is crucial for timely intervention and management.

Related Concept Videos

Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...